Texts may help hispanic sleep apnea patients stick with treatment

NCT ID NCT05618444

Not yet recruiting Symptom relief Sponsor: Geisinger Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a culturally tailored text-message program can help Spanish-speaking Hispanic adults with obstructive sleep apnea use their positive airway pressure (PAP) machine more consistently. Fifty adults will receive automated texts that offer support, troubleshooting, and motivation. The goal is to see if this approach is acceptable and satisfying to patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Automated text-message support program
What this could lead to: If it works, this could point toward a simple, low-cost way to help Spanish-speaking Hispanic adults stick with their sleep apnea treatment.
What could go wrong: This is a very small, early feasibility study with only 50 people. It focuses on satisfaction and acceptance, not on whether sleep or health actually improves.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBSTRUCTIVE SLEEP APNEA

Contacts and locations

Locations

Geisinger

Danville, Pennsylvania, 17821, United States
Kaiser Permanent Southern California

Fontana, California, 92335, United States
University of Kansas Medical Center

Kansas City, Kansas, 66160, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.